Clinical Trials Directory

Trials / Completed

CompletedNCT02452125

The Effects of Nicotine Chewing Gum in Parkinson's Disease

The Effects of Nicotine Chewing Gum on Acute Low Blood Pressure in Parkinson's Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
New York Institute of Technology · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of this experiment is: To determine if nicotine chewing gum will improve acute episodes of orthostatic hypotension in PD subjects.

Detailed description

Subjects will be asked to sit and rest for 10 minutes. Blood pressure will be taken in this resting position after the 10 minutes. After all inclusion criteria has been met, subjects will then wear an automated BP cuff and be administered 4mg of nicotine gum (Nicorette™). They will be instructed to use it according to manufacturer's directions and remain chewing the gum for 30 minutes. The subject will remain in a seated position and BP and HR will be recorded every 5 minutes for 30 minutes. After 30 minutes the gum will be removed and subjects will still have HR and BP monitored in the seated position for another hour every 10 minutes. All values will be compared to pretreatment values. After 120 minutes if the subject is non-symptomatic, they can go home.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNicotine gumNicotine chewing gum

Timeline

Start date
2015-05-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2015-05-22
Last updated
2017-07-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02452125. Inclusion in this directory is not an endorsement.